Another study employed unsupervised ML to categorize anti-melanoma differentiation-associated protein 5 (anti-MDA5) positive patients with dermatomyositis into three distinct subtypes and established a decision tree algorithm to forecast their clinical characteristics and prognosis. Here, IFIH1 is linked to dermatomyositis.